Synthesis of Peptide-Peptide Nucleic Acid Conjugates, Upcoming Webinar Hosted by Xtalks
Mesa Laboratories, Inc. (MLAB)
Last mesa laboratories, inc. earnings: 2/10 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
mesalabs.com/corporate
Company Research
Source: PR Web
TORONTO (PRWEB) August 19, 2021 Peptide nucleic acids (PNAs), developed by Peter Nielsen in the early 90's, constitute synthetic analogues of DNA and RNA, where the phosphodiester backbone of these natural oligonucleotides (ON) is replaced by a pseudopeptide structure. PNAs hybridize with complementary nucleic acid segments with higher affinity and specificity than natural ON, interfering with higher efficiency with target genes. Moreover, the unnatural backbone of PNAs makes them highly resistant to enzymatic degradation.These characteristics make them valuable tools for various applications, from diagnostics to therapeutics. Limitations to their versatility include poor water solubility and low nuclear targeting capability. However, these have been successfully circumvented by the introduction of chemical modifications to PNA sequences, such as cell-penetrating peptides, which have been proven to be highly valuable in drug delivery and gene therapy. Just as for peptides, PNAs can b
Show less
Read more
Impact Snapshot
Event Time:
MLAB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MLAB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MLAB alerts
High impacting Mesa Laboratories, Inc. news events
Weekly update
A roundup of the hottest topics
MLAB
News
- The past three years for Mesa Laboratories (NASDAQ:MLAB) investors has not been profitable [Yahoo! Finance]Yahoo! Finance
- Andvari Associates Q1 2024 Letter [Seeking Alpha]Seeking Alpha
- MESA LABS ANNOUNCES AMENDMENT TO CREDIT FACILITY AND REPURCHASE OF SENIOR CONVERTIBLE NOTESGlobeNewswire
- MESA LABS DECLARES QUARTERLY DIVIDENDGlobeNewswire
- Mesa Laboratories, Inc. (NASDAQ: MLAB) had its price target raised by analysts at Evercore ISI from $124.00 to $130.00. They now have an "outperform" rating on the stock.MarketBeat
MLAB
Earnings
- 2/5/24 - Beat
MLAB
Analyst Actions
- 4/4/24 - Evercore ISI Group
MLAB
Sec Filings
- 4/8/24 - Form 8-K
- 4/3/24 - Form 4
- 4/3/24 - Form 4
- MLAB's page on the SEC website